Top Markets
#1 aelf aelf +19.10%
#2 Status Status +12.67%
#3 ADO Protocol ADO Protocol +11.54%
#4 StonkBroker StonkBroker +10.16%
#5 TDCCP TDCCP +9.05%
#6 Magma Finance Magma Finance +8.17%
#7 Ontology Gas Ontology Gas +6.82%
#8 Mina Protocol Mina Protocol +5.37%
#9 TENDIES TENDIES +4.62%
#10 Wrapped Flare Wrapped Flare +4.38%
Coin of the day
aelf aelf
Settings
Language
ENGLISH
Currency
USD
Theme
Akums Drugs & Pharmaceuticals Ltd. Akums Drugs & Pharmaceuticals Ltd.

Akums Drugs & Pharmaceuticals Ltd.

AKUMS
Rank in Stocks #8292
Akums Drugs & Pharmaceuticals Ltd. is an Indian-based company, established in... Akums Drugs & Pharmaceuticals Ltd. is an Indian-based company, established in 2004 and headquartered in Delhi, that operates globally as a manufacturer and supplier of both finished pharmaceutical products and active pharmaceutical ingredients (APIs). Its diverse product range encompasses conventional drugs, traditional Ayurvedic and herbal remedies, personal care items including toiletries, nutraceuticals, food and dietary supplements, dermatological and cosmetic products, and healthcare and hospital supplies, along with over-the-counter (OTC) solutions. The company also deals in excipients and various chemical compounds. Akums develops and markets its own branded formulations across a variety of dosage forms, such as tablets, capsules, injectables, ophthalmic preparations, and soft gelatin capsules. These products address a broad spectrum of therapeutic areas, including gynaecology, cardiology, orthopaedics, pediatrics, dermatology, anti-infectives, pain management, and gastroenterology. Furthermore, Akums Drugs & Pharmaceuticals provides services as a pharmaceutical contract development and manufacturing organization (CDMO).
Share Price
$8.53
Last synced: 2026-08-28
Market Cap
$1.31B
Change (1 day)
1.50%
Change (1 year)
65.49%
Country
IN
Trade Akums Drugs & Pharmaceuticals Ltd. (AKUMS)

Category

Healthcare
Revenue for Akums Drugs & Pharmaceuticals Ltd. (AKUMS)
Revenue in Aug 2026 TTM: 0
According to Akums Drugs & Pharmaceuticals Ltd. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Akums Drugs & Pharmaceuticals Ltd. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 $6.61B -
IN